1 ly angiogenic tumors when implanted into the
nude mouse.
2 bility when inoculated subcutaneously in the
nude mouse.
3 nd were unable to form tumors in the athymic
nude mouse.
4 h of xenografted cervical tumor implanted in
nude mouse.
5 d human kidney xenografts of Caki-2 cells in
nude mouse.
6 nesis upon subcutaneous transplantation in a
nude mouse.
7 ted in hollow fibers and were implanted in a
nude mouse.
8 umors grew extensively in the transgenic GFP
nude mouse.
9 e winged-helix nude (whn) gene result in the
nude mouse and rat phenotypes.
10 s phenomenon with a human tumor growing in a
nude mouse and show that it is caused by secretion by th
11 y cells are injected subcutaneously into the
nude mouse,
and it converts human 293 cells from nontumo
12 utic efficacy of 212Pb-AE1 were evaluated in
nude mouse ascites or solid tumor models, wherein SK-OV-
13 Here we demonstrate that traditional
nude mouse assays impose an artificial anoikis and proli
14 ransforming in both soft-agar and orthotopic
nude mouse assays.
15 = 93), islet ATP content (n = 27), diabetic
nude mouse bioassay (n = 72), and the insulin secretory
16 Nude mouse bioassay demonstrated better islet function f
17 et isolation, in vitro potency assays, and a
nude mouse bioassay.
18 On-tissue enzymatic digestion of
nude mouse brain tissue permitted the detection of 43 N-
19 x derivative to induce new bone formation in
nude mouse calf muscle, or to enhance the bone induction
20 plantation under the renal capsule of a male
nude mouse confirmed a complete loss of VP determination
21 antisense virus, which were also tested in a
nude mouse diaphragm invasion model, showed suppression
22 through the layers and structures of ex vivo
nude mouse ear skin and extracted pharmacokinetic parame
23 l staining of sections of M. leprae-infected
nude mouse footpads resulted in strongly positive staini
24 atient with DLL and propagated it in athymic
nude mouse footpads.
25 We report here a novel transgenic
nude mouse for the visualization of human tumor angiogen
26 appendage formation, we have been studying a
nude mouse grafting model that permits the combination o
27 ras in culture or benign tumor formation in
nude mouse grafts, disruption of this pathway impairs gr
28 tion assay, we demonstrate that the abnormal
nude mouse hair development is attributable to a functio
29 r part of the whisker follicles and targeted
nude-mouse hair follicles, which are genetically deficie
30 ing C2C12 myoblasts were grafted into normal
nude mouse hearts.
31 a mutant HhaI control) and tumorigenicity in
nude mouse heterotransplants (75% for sense HhaI-transdu
32 When regrafted to
nude mouse hosts epithelial cells isolated from CAF- or
33 v-ras(Ha) encoding retrovirus and grafted to
nude mouse hosts to test whether the p53 null phenotype
34 mesenchyme and implanted into athymic male,
nude mouse hosts, the recombinants developed into fully
35 mbryos under the renal capsule of adult male
nude mouse hosts.
36 group of five compounds was evaluated in the
nude mouse HT-29 xenograft model.
37 eraction of these two agents in vivo using a
nude mouse HT29 xenograft tumor model.
38 n preclinical efficacy against p53-deficient
nude mouse-
human ovarian carcinomatosis xenografts.
39 or intravenous administration of ONYX-015 to
nude mouse-
human tumor xenografts; efficacy with ONYX-01
40 cerebral cortex in the congenitally athymic
nude mouse is related to the thymus, a gland necessary f
41 Furthermore,
nude mouse keratinocytes displayed a 100-fold increased
42 ty observed for both 14 and 15 in an athymic
nude mouse MDA-MB-231 human breast cancer xenograft mode
43 xpression of Smurf2 promotes metastasis in a
nude mouse model and increases migration and invasion of
44 as found to selectively target human KS in a
nude mouse model and inhibit tumor growth at a therapeut
45 eatment with INH1 retarded tumor growth in a
nude mouse model bearing xenografts derived from the hum
46 ssing Cox-2 had aggressive tumor growth in a
nude mouse model compared with control cells.
47 The ND-GFP transgenic
nude mouse model enables the visualization of nascent an
48 and metastasis in vivo, we used a xenograft
nude mouse model generated by means of subcutaneous or t
49 In a colon tumor
nude mouse model in vivo, mAb 4H6 treatment without addi
50 Tumor formation in a
nude mouse model is inhibited by TRC8 in a RING-dependen
51 The treatment was applied to a GBM xenograft
nude mouse model obtained by injecting 2 x 106 U87 luc+
52 patient-derived orthotopic xenograft (PDOX)
nude mouse model of a highly aggressive liver metastasis
53 leukemia mouse model and shows efficacy in a
nude mouse model of chronic myelomonocytic leukemia.
54 nsional culture and in an in vivo orthotopic
nude mouse model of HNSCC through a novel transcription-
55 In a
nude mouse model of human fibrosarcoma, we show that the
56 Using a xenograft
nude mouse model of human glioblastoma multiforme, block
57 )PE38 was tested for antitumor activity in a
nude mouse model of human lymphoma.
58 ibody can extend survival significantly in a
nude mouse model of human ovarian cancer at levels that
59 In an orthotopic
nude mouse model of human pancreatic cancer, p.o. admini
60 asis of uveal melanoma cells was tested in a
nude mouse model of intraocular melanoma.
61 ing a mutant cyclin G1 (dnG1) construct in a
nude mouse model of liver metastasis.
62 lin, was studied in vitro and in the athymic
nude mouse model of microsporidiosis.
63 ssue factor, EPCR or PAR1, and an orthotopic
nude mouse model of MPM.
64 encapsulated endostatin-secreting cells in a
nude mouse model resulted in a 72.3% reduction in subcut
65 ession of neuroblastoma in children and in a
nude mouse model system.
66 These results were confirmed in vivo in
nude mouse model system.
67 umor xenografts, to regain tumorigenicity in
nude mouse model systems.
68 In a
nude mouse model using LNCaP cells, the hyperfusogenic P
69 Xenograft tumor in a
nude mouse model was used to explore the role of circRNA
70 In this study, a
nude mouse model was used to test whether combinations o
71 l lines and a spleen subcapsular inoculation
nude mouse model were also used.
72 ments in vivo were carried out in an athymic
nude mouse model with an i.m. xenograft of LNCaP cells.
73 Hy-LNCs was finally assessed in vivo using a
nude mouse model with transplanted tumours.
74 In the
nude mouse model, levels of radioactivity in tumor reach
75 In a
nude mouse model, OPG treatment completely prevented rad
76 duced the growth of the HT-29 xenograft in a
nude mouse model, suggesting that 3b is a promising new
77 vivo the growth of the HT-29 xenograft in a
nude mouse model, suggesting that 4l is a promising new
78 enesis and liver metastasis in an orthotopic
nude mouse model, suggesting that constitutive NF-kappaB
79 tumor growth and metastasis in an orthotopic
nude mouse model, the proapoptotic potency of Bik can be
80 In the NMRI
nude mouse model, we observed up to a 4.5-fold increase
81 c cancer cell line, PANC-1, in an orthotopic
nude mouse model.
82 e as a means of delivery to tumor sites in a
nude mouse model.
83 human breast tumors from an in vivo athymic
nude mouse model.
84 sis, growth, and metastasis in an orthotopic
nude mouse model.
85 r-induced angiogenesis and tumor growth in a
nude mouse model.
86 ess angiogenesis and growth in an orthotopic
nude mouse model.
87 pressed the growth of renal cell cancer in a
nude mouse model.
88 n in vitro and tumor growth in an orthotopic
nude mouse model.
89 elayed MPNST formation in an MPNST xenograft
nude mouse model.
90 h in human pancreatic cancer xenografts in a
nude mouse model.
91 TUD5 knockdown accelerates tumor growth in a
nude mouse model.
92 ility in vitro and pulmonary metastasis in a
nude mouse model.
93 tenuated human pancreatic cancer growth in a
nude mouse model.
94 cally implanted human colorectal cancer in a
nude mouse model.
95 lony formation, as well as tumor growth in a
nude mouse model.
96 genic potential of ovarian cancer cells in a
nude mouse model.
97 he cell culture model and in a tumorigenesis
nude mouse model.
98 te cancer LNCaP cells to distant organs in a
nude mouse model.
99 (via orthotopical injection) in a xenograft
nude mouse model.
100 ncer in vivo was assessed with an orthotopic
nude mouse model.
101 lls in a fluorescent, orthotopic, metastatic
nude-mouse model of human prostate cancer.
102 Athymic
nude mouse models are used to guide radioimmunotherapy i
103 ty for CD22+ cells and antitumor activity in
nude mouse models bearing human B-cell lymphomas.
104 In
nude mouse models GFB-111 also shows significant inhibit
105 to surgical navigation was demonstrated in 2
nude mouse models that represent difficult surgical chal
106 In orthotopic
nude mouse models, dasatinib treatment effectively inhib
107 or and kidney uptake in pancreatic xenograft
nude mouse models, including AR42J.
108 ctive cytotoxicity to tumours in culture and
nude mouse models.
109 in human prostate PC-3 and DU-145 xenograft
nude mouse models.
110 etastatic invasion using in vitro assays and
nude mouse models.
111 and tumorigenicity and growth in orthotopic
nude mouse models.
112 etastases in ectopic or orthotopic xenograft
nude mouse models.
113 cancer cells in 4T1.2 BALB/cJ and MDA-MB-231
nude mouse models.
114 Both in vitro and in vivo (
nude mouse)
models were used for growth assays.
115 lls in vitro, tumor growth inhibition in the
nude mouse of human A375 melanoma xenografts resulted fr
116 d with PTEN cDNA were tested for growth in a
nude mouse orthotopic brain tumor model.
117 Using a
nude mouse orthotopic xenograft model, we assessed the e
118 ovarian carcinoma heterotransplanted in the
nude mouse (
OVCAR-3).
119 periodically imaged intravitally in a single
nude mouse over a 19-day period.
120 oliferation index (P > 0.1) in an orthotopic
nude mouse PaCa model.
121 nd hair bulb and other areas of the resident
nude mouse pelage follicles where they differentiated to
122 The resident
nude-mouse pelage follicles targeted by jumping whisker
123 forkhead transcription factor, result in the
nude mouse phenotype.
124 Examination of
nude mouse primary keratinocytes in culture revealed tha
125 a LCI-D35 were orthotopically implanted into
nude mouse prostate and liver, respectively.
126 mportantly, when orthotopically implanted in
nude mouse prostate, both 15-LOX2 and 15-LOX2sv-b suppre
127 om a 24-h FTI infusion to that of a DPI in a
nude mouse/
PSN-1 tumor cell xenograft model and in Ki-ra
128 ly examined MMP-2 in live cells and tumor on
nude mouse,
respectively.
129 In the
nude mouse,
SCH 66336 demonstrated potent oral activity
130 All athymic
nude mouse strains showed active infections at both cuta
131 nt, beige natural killer cell-deficient, and
nude mouse strains.
132 In vitro clonogenic and in vivo
nude mouse studies showed that overexpression of the A a
133 melanoma cell line to become metastatic in a
nude mouse system.
134 in both CD4(+)- and CD8(+)-depleted mice and
nude mouse systems, indicating that the therapeutic effe
135 iphasic, in vivo tumor growth pattern in the
nude mouse that is essentially identical to EBV-positive
136 An athymic
nude mouse that received a s.c. implant of a primary NE
137 When tested in
nude mouse,
the average size of tumours produced by PC-3
138 y, these in vitro results were replicated in
nude mouse transplanted tumor models.
139 Finally, in a
nude mouse tumor xenograft model, Cuc Q, but not Cuc A,
140 and induces p21(WAF1) and MDM2 expression in
nude mouse tumor xenografts.
141 s cell carcinoma using gene transfer and the
nude mouse tumorigenesis assay.
142 activities in both cell colony formation and
nude mouse tumorigenicity assays.
143 optosis, and inhibition of tumor growth in a
nude mouse tumoriginicity model.
144 A dose-escalation study of this agent in a
nude mouse U87 glioma model system demonstrated a concen
145 The GFP
nude mouse was obtained by crossing nontransgenic nude m
146 varian carcinoma) xenograft grown in athymic
nude mouse window chambers.
147 e transgenic green fluorescent protein (GFP)
nude mouse with ubiquitous GFP expression.
148 g from 5.6 to 9.3 MBq (150--250 microCi) per
nude mouse,
with no significant difference in response r
149 d growth of human colon carcinoma cells in a
nude mouse xenograft assay and was accompanied by a sign
150 ion and a marked decrease in tumor growth in
nude mouse xenograft assays.
151 K inhibitory potency and greater efficacy in
nude mouse xenograft assays.
152 ial applications of this result, we used the
nude mouse xenograft model of carcinogenesis.
153 In vivo tests in a
nude mouse xenograft model of human pancreatic cancer (M
154 CD44 in ovarian cancer metastasis by using a
nude mouse xenograft model of peritoneal implantation.
155 We have previously shown in a
nude mouse xenograft model that restoration of CEACAM1(a
156 nd paclitaxel treatments were evaluated in a
nude mouse xenograft model using ARO and KAT-4 cells.
157 regulation on tumor growth was analyzed in a
nude mouse xenograft model.
158 s tested and prevented glioma formation in a
nude mouse xenograft model.
159 in a MDR human non-small cell lung carcinoma
nude mouse xenograft model.
160 in also inhibited tumor growth in an athymic
nude mouse xenograft model.
161 -PP inhibited Her-2/neu tumor formation in a
nude mouse xenograft model.
162 ic to highly tumorigenic and metastatic in a
nude mouse xenograft model.
163 EphA2 siRNA treatment was assessed in a
nude mouse xenograft model.
164 lls, and is efficacious in the Min mouse and
nude mouse xenograft models of colon cancer.
165 TTI-237 was active in vivo in several
nude mouse xenograft models of human cancer, including L
166 IFN-beta) cDNA was delivered systemically in
nude mouse xenograft models of human colorectal cancer l
167 Concurrent dosing in
nude mouse xenograft models of human lung adenocarcinoma
168 ation with Adriamycin (ADR) or paclitaxel in
nude mouse xenograft models of human osteosarcoma and no
169 ere shown to inhibit tumor growth in several
nude mouse xenograft models, with high potency and effic
170 demonstrated in our tumorigenesis studies in
nude mouse xenograft models.
171 itory activity against human glioblastoma in
nude mouse xenograft models.
172 inst human glioblastoma in cell cultures and
nude mouse xenograft models.
173 In
nude mouse xenograft settings, iso-fludelone was able to
174 In
nude mouse xenograft studies, 27 reduced PSA levels by 9
175 In
nude mouse xenograft studies, 5 reduced circulating PSA
176 Experiments using a
nude mouse xenograft system show that Schwann cells expr
177 In a
nude mouse xenograft tumor model, the (67)Ga-complex pro
178 However, when compared in vivo in
nude mouse xenograft tumor models, E2F/GM/E3b spread thr
179 Growth suppression of
nude mouse xenograft tumors carrying a tetracycline-indu
180 s to lung and regional lymph nodes from s.c.
nude mouse xenografts and were found to express P-select
181 cancer cell growth in culture as well as in
nude mouse xenografts by inhibiting the NF-kappaB-depend
182 In vivo,
nude mouse xenografts established from SULF2-transfected
183 thium preferentially inhibited the growth of
nude mouse xenografts of HCT-116 colon cancer cells with
184 acy was assessed using zebrafish xenografts,
nude mouse xenografts, and syngeneic orthotopic mouse mo
185 In
nude mouse xenografts, GGTI-2418 suppresses the growth o
186 iminate established tumors within 6 weeks in
nude mouse xenografts.
187 minated established tumors within 6 weeks in
nude mouse xenografts.
188 gulated by this system, both in vitro and in
nude mouse xenografts.
189 mation, formed foci in culture and tumors in
nude mouse xenografts.
190 n of GPC3 and tumor growth were confirmed in
nude mouse xenografts.
191 es with a reduced ability to form tumours in
nude mouse xenografts.
192 clearance, and timing for signal capture in
nude mouse xenografts.
193 y and did not form tumors following human-to-
nude mouse xenotransplantation.